Back to search

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C

Data up to Jan 2025

Published2005
Citations2,424
References39

Total Citations Per Year

Abstract

References (39)

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

2003 • 4,023 citations

An algorithm for the grading of activity in chronic hepatitis C

1996 • 3,858 citations

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis

2003 • 2,619 citations

Sampling variability of liver fibrosis in chronic hepatitis C

2003 • 2,191 citations

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

2002 • 1,981 citations

Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

1994 • 1,968 citations

Liver Biopsy

2001 • 1,920 citations

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

2001 • 1,432 citations

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

2002 • 1,078 citations

Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey

2000 • 986 citations

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

2003 • 861 citations

SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER

1986 • 606 citations

Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics

2004 • 416 citations

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

1997 • 365 citations

The role of liver biopsy in chronic hepatitis C

2002 • 354 citations

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material

1993 • 353 citations

Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C

2004 • 347 citations

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

2003 • 254 citations

Validation of the FibroTest Biochemical Markers Score in Assessing Liver Fibrosis in Hepatitis C Patients

2003 • 243 citations

Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis

1996 • 242 citations

National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002

2002 • 226 citations

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

2002 • 221 citations

Role of liver biopsy in management of chronic hepatitis C: A systematic review

2002 • 210 citations

Noninvasive monitoring of patients with chronic hepatitis C

2002 • 203 citations

Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists.

1996 • 182 citations

Sampling Variability on Percutaneous Liver Biopsy in Patients with Chronic Hepatitis C Virus Infection

2003 • 177 citations

One-Second Biopsy of the Liver — Problems of Its Clinical Application

1970 • 138 citations

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

2004 • 134 citations

Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?

2003 • 132 citations

Role of liver biopsy in management of chronic hepatitis C: A systematic review

2002 • 123 citations

Efficacy of non-invasive elastometry on staging of hepatic fibrosis

2004 • 95 citations

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C

2002 • 90 citations

Noninvasive monitoring of patients with chronic hepatitis C

2002 • 90 citations

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.

2003 • 88 citations

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C

2003 • 82 citations

68 Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C

2003 • 17 citations

576 Liver elasticity measurement by ultrasonic transient elastography: a new non-invasive method for assessment of liver fibrosis in chronic viral hepatitis

2003 • 4 citations

459 Correlation between liver elasticity measured by transient elastography and liver fibrosis assessed by morphometry in patients with HCV chronic hepatitis

2004 • 4 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for… (2005) – Gastroenterology | Metascience Observatory Explorer